- PACB +0.49%
Search results
- 2.0500Add to watchlist+0.0100 (+0.49%)At close:4:00 PM EDTThu. Jun 6, 20242.0993 +0.05 (+2.40%)After hrs:7:43 PM EDTThu. Jun 6, 2024Nasdaq Real Time Price (USD) · Market closed
- Open2.0300High2.1697Low1.9800
- Mkt Cap558.33MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close2.040052 Wk. Low1.250052 Wk. High14.5500
Top storiesPacific Biosciences of California, Inc. (PACB) Is a Trending Stock: Facts to Know Before Betting on ItYahoo Finance · 2 weeks agoRelated stocks
May 17, 2024 · Get the latest stock price, quote, news and history of PACB, a biotechnology company that develops and sells sequencing systems and services. See the bid, ask, volume, market cap, earnings, dividend and other data of PACB on Nasdaq.
2 days ago · PacBio is a company that develops sequencing technologies for genomics research and applications. See its stock price, change, volume, and 52-week range, as well as its presentations and investor contact information.
3 days ago · Stock analysis for Pacific Biosciences of California Inc (PACB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
- 796
1 day ago · Get the latest information on PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms. See the stock price, earnings, revenue, news, analysts' ratings and more.
3 days ago · View Pacific Biosciences of California, Inc PACB investment & stock information. Get the latest Pacific Biosciences of California, Inc PACB detailed stock quotes, stock data, Real-Time ECN, charts ...
May 28, 2024 · PACB is a biotechnology company that develops sequencing solutions for genetic analysis. It has a low price/sales ratio, a negative return on equity, and a high uncertainty rating. See its latest financial results, news, and comparables.
People also ask
What does PACB stand for?
Should you buy Pacific Biosciences of California (PACB) stock?
Where can I buy PACB stock?
Who owns Pacific Biosciences of California stock?
2 days ago · 16 Wall Street analysts have issued 12-month target prices for Pacific Biosciences of California's shares. Their PACB share price targets range from $2.00 to $15.00. On average, they predict the company's share price to reach $6.38 in the next year. This suggests a possible upside of 212.5% from the stock's current price.